NAII

Clinical Trial Results: Natural Alternatives International, Inc. announced that their TriBsyn™ beta-alanine complex significantly increases bioavailability and efficiency while eliminating the common side effect of paresthesia, as published in the journal Food Hydrocolloids for Health.

Product Innovation: TriBsyn™, utilizing proprietary Hydro Oleo technology, offers a higher potency and better absorption of beta-alanine, making it suitable for active aging populations and those seeking enhanced muscle vitality and cognitive performance without discomfort.

New Distribution Partnership: Natural Alternatives International, Inc. has partnered with B&D Nutritional Ingredients to distribute its new carnosine booster, TriBsyn™, targeting the U.S. dietary supplement market.

Product Benefits: TriBsyn™ is designed to enhance beta-alanine absorption without causing the typical paresthesia sensation, aiming to benefit various consumer groups including older adults and those seeking cognitive and physical health support.

Financial Performance: Natural Alternatives International, Inc. reported a net loss of $1.9 million for Q4 2024, with total sales decreasing by 18% to $29.5 million compared to the previous year, leading to an annual net loss of $7.2 million.

Future Outlook: Despite recent losses, the company anticipates improved sales in fiscal 2025, projecting a net loss in the first half but expecting profitability in the second half, bolstered by new business opportunities and product introductions like their TriBsyn™ ingredient.

Exhibition at ESPEN Congress: Natural Alternatives International, Inc. (NAI) and CarnoSyn® Brands will showcase their new product TriBsyn™ at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan from September 7-10, 2024, highlighting its benefits for muscle vitality and cognitive performance.

Innovative Product Features: TriBsyn™ is a patent-pending formula designed to enhance beta-alanine absorption without causing the typical paresthesia sensation, targeting a broader consumer base including older adults and vegans, and expanding NAI's offerings in dietary supplements and fortified foods.

Introduction of TriBsyn™: Natural Alternatives International, Inc. has launched TriBsyn™, a new carnosine booster that enhances beta-alanine absorption while eliminating the common side effect of paresthesia, making it suitable for a wider audience including older adults and those on plant-based diets.

Health Benefits and Market Expansion: TriBsyn™ is scientifically proven to improve cognitive performance, muscle function in older adults, and slow age-related decline, positioning NAI to expand its presence in dietary supplements and meet the growing demand for wellness solutions.

Exhibition at ESPEN Congress: Natural Alternatives International, Inc. and CarnoSyn® Brands will showcase their new product TriBsyn™ at the 46th ESPEN Congress on Clinical Nutrition & Metabolism in Milan from September 7-10, 2024, highlighting its benefits for muscle vitality and cognitive performance without the common side effects of beta-alanine.

Broadened Product Offerings: The introduction of TriBsyn™, a "paresthesia-free" formula, allows NAI to expand its dietary supplement range, catering to various consumer needs including older adults and vegans, while also participating in the upcoming European Geriatric Medicine Society Congress in Valencia.